Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.

Pagliaro, L C; Liu, B; Munker, R; Andreeff, M; Freireich, E J; Scheinberg, D A; Rosenblum, M G

Pagliaro, L C; Liu, B; Munker, R; Andreeff, M; Freireich, E J; Scheinberg, D A; Rosenblum, M G.

Affiliation

Pagliaro LC; Division of Medicine, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Clin Cancer Res ; 4(8): 1971-6, 1998 Aug.

Article in En | MEDLINE | ID: mdl-9717827

Subject(s)

Antibodies, Monoclonal/pharmacology; Antigens, CD/immunology; Antigens, Differentiation, Myelomonocytic/immunology; Antineoplastic Agents, Phytogenic/pharmacology; Immunotoxins/pharmacology; Leukemia, Myeloid, Acute/drug therapy; Plant Proteins/pharmacology; Antibodies, Monoclonal/immunology; Bone Marrow Transplantation; Cryopreservation; Humans; Leukemia, Myeloid, Acute/pathology; Recombinant Proteins/pharmacology; Ribosome Inactivating Proteins, Type 1; Sensitivity and Specificity; Sialic Acid Binding Ig-like Lectin 3; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plant Proteins / Antigens, Differentiation, Myelomonocytic / Leukemia, Myeloid, Acute / Antigens, CD / Immunotoxins / Antibodies, Monoclonal / Antineoplastic Agents, Phytogenic Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 1998 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links